Texas Instruments: Buy On Pullbacks

Texas Instruments remains rated Buy, supported by 30% Y/Y industrial growth and 90% Y/Y data center revenue growth. Industrial sales are still 15% below the 2022 peak, implying additional upside in the company’s highest-margin segment. Management also pointed to increased design-ins and sustained demand extending into H2 2026 and 2027, reinforcing a constructive outlook for margins and free cash flow.

Analysis

TXN’s setup is not just a cyclical recovery; it is a mix-shift story where incremental revenue is landing in the most operating-levered parts of the portfolio. That matters because industrial and data-center demand tends to be stickier than headline semis demand, so the market may still be underestimating how much of the next leg of margin expansion can come from utilization rather than price. If that mix holds, consensus EPS revisions likely lag the share price for a few quarters, which is typically when TXN multiple expansion can persist.

The second-order winner is the broader industrial automation and power-chain ecosystem: stronger analog demand usually pulls through at the component, test, and equipment layers before it shows up in end-market capex data. Competitors with heavier consumer/handset exposure are the likely relative losers, because they lack the same pricing discipline and long-duration design-win visibility. On the supply side, sustained demand into 2026-2027 reduces the odds of another inventory-clearing downturn, which is positive for backlog quality but could pressure peers that still need channel destocking to finish.

The main risk is timing, not thesis. If industrial growth decelerates over the next 1-2 quarters or data-center demand proves front-loaded, the stock could de-rate before the FCF compounding shows up in numbers. Watch for any signs that the design-in pipeline is converting slower than expected, because that would be the cleanest way to break the long-duration demand argument.

The contrarian angle is that the market may already be paying for a “high-quality secular compounder” narrative, while the real catalyst is still several quarters away. That creates a window where the stock can outperform on guidance tone but underdeliver if investors expect immediate acceleration in reported revenue. In other words: the fundamental story is strong, but the easy money may already be in the move unless the next two prints confirm follow-through.

Key Decisions for Investors

• Stay long TXN for 3-6 months into the next two earnings cycles; risk/reward favors holding as long as industrial growth stays >20% Y/Y and FCF conversion remains elevated.
• Buy TXN call spreads 6-9 months out to express upside from margin expansion without paying full delta; best structure is an at-the-money / +15% spread if implied vol is elevated.
• Pair trade: long TXN / short a more cyclical analog peer with weaker data-center exposure for 1-2 quarters; this isolates mix-quality and margin durability rather than sector beta.
• If TXN rallies sharply on the next print, trim 20-30% and trail the rest with a 10% stop; the main risk is multiple compression before revenue catches up.
• Use any 5-8% post-earnings pullback to add; the best entry is likely on guidance-related volatility rather than chasing strength after a run-up.